Showing results (141-150 of 226) with videos related to
Sort By:
Pageof 23
BJOG : an International Journal of Obstetrics and Gynaecology|May 11, 2023
Prognostic impact of cytoreductive surgery conducted with primary intent, versus cytoreductive surgery after neoadjuvant chemotherapy, in the management of patients with advanced epithelial ovarian cancers: a multicentre, propensity score-matched study from the FRANCOGYN groupHenri Wohrer, Meriem Koual, Enrica Bentivegna, et al.Annals of Surgical Oncology|February 2, 2023
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective StudyFlorian Fanget, Amaniel Kefleyesus, Julien Peron, et al.Journal of Gynecologic Oncology|January 12, 2024
Confirmation of the utility of the CA-125 elimination rate (KELIM) as an indicator of the chemosensitivity in advanced-stage ovarian cancer in a "real-life setting"Lilian van Wagensveld, Olivier Colomban, Maaike A van der Aa, et al.Homeopathy : the Journal of the Faculty of Homeopathy|December 3, 2014
Open-label uncontrolled pilot study to evaluate complementary therapy with Ruta graveolens 9c in patients with advanced cancerGilles Freyer, Benoit You, Stéphanie Villet, et al.Cancers|December 11, 2019
Are Older Patients with Cervical Cancer Managed Differently to Younger Patients? An International SurveyMaxime Frelaut, Nienke De Glas, Ignacio Zapardiel, et al.Cancer Chemotherapy and Pharmacology|September 23, 2015
Etoposide pharmacokinetics impact the outcomes of lymphoma patients treated with BEAM regimen and ASCT: a multicenter study of the LYmphoma Study Association (LYSA)Benoit You, Gilles Salles, Emmanuel Bachy, et al.Urology|May 18, 2010
Predictive value of modeled AUC(AFP-hCG), a dynamic kinetic parameter characterizing serum tumor marker decline in patients with nonseminomatous germ cell tumorBenoit You, Ludivine Fronton, Helen Boyle, et al.Ebiomedicine|February 21, 2023
Mathematical modeling of the early modeled CA-125 longitudinal kinetics (KELIM-PARP) as a pragmatic indicator of rucaparib efficacy in patients with recurrent ovarian carcinoma in ARIEL2 & STUDY 10Olivier Colomban, Elizabeth M Swisher, Rebecca Kristeleit, et al.Journal of Clinical Medicine|May 17, 2020
Management and Survival of Elderly and Very Elderly Patients with Ovarian Cancer: An Age-Stratified Study of 1123 Women from the FRANCOGYN GroupYolaine Joueidi, Ludivine Dion, Sofiane Bendifallah, et al.British Journal of Clinical Pharmacology|September 22, 2022
Effect of capmatinib on the pharmacokinetics of substrates of CYP3A (midazolam) and CYP1A2 (caffeine) in patients with MET-dysregulated solid tumoursXinhui Chen, Nicolas Isambert, Rafael López-López, et al.Pageof 23